Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study of Tadalafil for Duchenne Muscular Dystrophy

ClinicalTrials.gov ID: NCT01865084

Public ClinicalTrials.gov record NCT01865084. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Tadalafil for Duchenne Muscular Dystrophy

Study identification

NCT ID
NCT01865084
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
331 participants

Conditions and interventions

Interventions

  • Tadalafil Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
7 Years to 14 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2013
Primary completion
Nov 30, 2015
Completion
Feb 29, 2016
Last update posted
Oct 8, 2019

2013 – 2016

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
Cedars Sinai Medical Center Los Angeles California 90048
University of California, Davis - Health Systems Sacramento California 95817
Children's Hospital Aurora Colorado 80045
University of Florida Health Science Center Gainesville Florida 32610
NW Florida Clinical Research Group Gulf Breeze Florida 32561
Nemours Children's Hospital Orlando Florida 32827
Ann and Robert Lurie Children's Hospital of Chicago Chicago Illinois 60611
University of Iowa Iowa City Iowa 52242
University of Kansas Medical Center Kansas City Kansas 66160
Washington University Medical Center St Louis Missouri 63110
Carolinas Healthcare System Charlotte North Carolina 28203
Duke University Medical Center Durham North Carolina 27705
Childrens Hospital Medical Center Cincinnati Ohio 45229
Oregon Health and Science University Portland Oregon 97239
Pennsylvania State University College of Medicine Hershey Pennsylvania 17033
Childrens Hospital of Philadelphia Philadelphia Pennsylvania 19104
Childrens Hospital of Pittsburgh Pittsburgh Pennsylvania 15224
Vanderbilt University Medical Center Nashville Tennessee 37232
Children's Medical Center Dallas Dallas Texas 75207
Univ of Texas Health Science Center at San Antonio San Antonio Texas 78229
University of Utah School of Medicine Salt Lake City Utah 84132
Children of the King's Daughters Norfolk Virginia 23510
Seattle Children's Hospital Research Foundation Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01865084, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 8, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01865084 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →